Saitama, Japan

Takeo Kawaguchi

This inventor holds 1 USPTO granted patent. Top assignees: Josai University Corporation, Nelson-Sumisho Co., Ltd.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takeo Kawaguchi. Retrieved from https://idiyas.com/inventor/takeo-kawaguchi-o2k3hh9r

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Takeo Kawaguchi: Innovator in Medical Administration

Introduction

Takeo Kawaguchi is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of medical administration, particularly in the treatment of AIDS. His innovative approach has led to the development of a unique method for administering essential medication.

Latest Patents

Kawaguchi holds a patent for a method titled "Percutaneous administration of 3'-azide'-deoxythymidine." This patent describes a technique for administering 3'-azide-3'-deoxythymidine (AZT) to AIDS patients. The method involves applying AZT to the skin along with an absorption-promoting agent that enhances the drug's absorption into the bloodstream. This innovative approach aims to improve the efficacy of AZT treatment for patients in need.

Career Highlights

Throughout his career, Kawaguchi has worked with various organizations, including Nelson-Sumisho Co., Ltd. and Josai University Corporation. His experience in these institutions has contributed to his expertise in medical innovations and patent development.

Collaborations

Kawaguchi has collaborated with notable individuals in his field, including Toshinobu Seki and Yasunori Morimoto. These partnerships have likely enriched his research and development efforts.

Conclusion

Takeo Kawaguchi's contributions to medical administration through his innovative patent demonstrate his commitment to improving patient care. His work continues to influence the field and offers hope for enhanced treatment options for AIDS patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…